anlak storytelling
All kinds
Document kinds
Loading document kinds...

Primary corpus lens for browsing and insights. Selection lives in the URL.

All formats
Orientation
Loading formats...

Landscape, portrait, square, or unknown document geometry.

Unlock
slides · global inventory

All filtered slides

Global slide inventory for the active corpus filters, with each row opening the slide detail view.

Search Insights JSON Unlock
Corpus coverage

319,975 slides

319,974 are described (100%), so the treemap can explain the corpus instead of just counting files.

Total slides
319,975
Described
319,974
Pending
1

Slide type composition

dynamicclickable
Slide type

Showing 319,974 described slides — 100.0% of 319,975 rendered pages

+Context & problem43,76713.7% · 6,592 docs+Data & charts72,62022.7% · 8,666 docs+Meta & navigation45,93614.4% · 9,739 docs+Recommend & act67,04121.0% · 9,324 docs+Cases & evidence31,2569.8% · 6,067 docs+Frameworks2,1230.7% · 1,232 docs+Appendix35,68211.2% · 6,614 docs+Other21,5496.7% · 5,566 docs

Tile area is proportional to slide count. Click a category to open its subtype map.

all document kinds · all orientations
18 30 60

Slide collection

165,301-165,360 of 319,975

filter-aware
10
The slide uses a central hub-and-spoke diagram to connect technology platforms (mRNA, T-cell, Antibodies, Small Molecules, Ribologicals) to therapeutic applications.BioNTech | Results Presentation Deck | 43 slides · BioNTech
Conference presentation Investor relations Beat · SolutionLoop · Golden Circle1 hit
11
BioNTech | Results Presentation Deck | 43 slidesBioNTech | Results Presentation Deck | 43 slides · BioNTech
Conference presentation Investor relations Beat · SolutionLoop · Golden Circle1 hit
12
BioNTech | Results Presentation Deck | 43 slidesBioNTech | Results Presentation Deck | 43 slides · BioNTech
Conference presentation Investor relations Beat · SolutionLoop · Golden Circle1 hit
13
The slide highlights BioNTech's global reach and commitment to equitable access.BioNTech | Results Presentation Deck | 43 slides · BioNTech
Conference presentation Investor relations Beat · SolutionLoop · Golden Circle1 hit
14
BioNTech | Results Presentation Deck | 43 slidesBioNTech | Results Presentation Deck | 43 slides · BioNTech
Conference presentation Investor relations Beat · SolutionLoop · Golden Circle1 hit
15
Includes clinical trial data for BNT162b2 vs placebo.BioNTech | Results Presentation Deck | 43 slides · BioNTech
Conference presentation Investor relations Beat · SolutionLoop · Golden Circle1 hit
16
Includes a dot plot for antibody titers, a sequence alignment table for T-cell epitopes, and a summary table for real-world effectiveness.BioNTech | Results Presentation Deck | 43 slides · BioNTech
Conference presentation Investor relations Beat · SolutionLoop · Golden Circle1 hit
17
The slide uses a numbered process flow combined with a data table to show clinical trial progression.BioNTech | Results Presentation Deck | 43 slides · BioNTech
Conference presentation Investor relations Beat · SolutionLoop · Golden Circle1 hit
18
Includes two sets of bar charts comparing neutralizing titers across age groups and vaccine doses.BioNTech | Results Presentation Deck | 43 slides · BioNTech
Conference presentation Investor relations Beat · SolutionLoop · Golden Circle1 hit
19
BioNTech | Results Presentation Deck | 43 slidesBioNTech | Results Presentation Deck | 43 slides · BioNTech
Conference presentation Investor relations Beat · SolutionLoop · Golden Circle1 hit
20
The slide uses a hub-and-spoke style diagram to illustrate how different therapeutic modalities (mRNA, CAR-T, Antibodies, Small Molecules, Engineered Biologicals) contribute to two main strategic pillars: Targeting Cancer and Immunomodulation.BioNTech | Results Presentation Deck | 43 slides · BioNTech
Conference presentation Investor relations Beat · SolutionLoop · Golden Circle1 hit
21
The slide uses a timeline-like visual representation for clinical phases.BioNTech | Results Presentation Deck | 43 slides · BioNTech
Conference presentation Investor relations Beat · ProductLoop · Golden Circle1 hit
22
The slide uses a combination of a conceptual process diagram and flow cytometry data plots to validate the mechanism of action.BioNTech | Results Presentation Deck | 43 slides · BioNTech
Conference presentation Investor relations Beat · ProductLoop · Golden Circle1 hit
23
The slide uses a combination of quantitative metrics and qualitative clinical context to establish the problem.BioNTech | Results Presentation Deck | 43 slides · BioNTech
Conference presentation Investor relations Beat · ProductLoop · Golden Circle1 hit
24
Includes a citation to a Nature publication and a visual representation of the mRNA construct.BioNTech | Results Presentation Deck | 43 slides · BioNTech
Conference presentation Investor relations Beat · ProductLoop · Golden Circle1 hit
25
Clinical trial design diagram showing randomization of 120 patients into three arms.BioNTech | Results Presentation Deck | 43 slides · BioNTech
Conference presentation Investor relations Beat · ProductLoop · Golden Circle1 hit
26
The slide uses a geographic map to illustrate disease prevalence and a table to highlight low ORR and mOS for existing therapies.BioNTech | Results Presentation Deck | 43 slides · BioNTech
Conference presentation Investor relations Loop · Golden Circle1 hit
27
The slide uses a diagram to illustrate the mRNA structure of BNT113 encoding HPV-E6 and HPV-E7.BioNTech | Results Presentation Deck | 43 slides · BioNTech
Conference presentation Investor relations Loop · Golden Circle1 hit
28
Includes patient-level response table, pie chart of response types, and visual ELISPOT assay results for patients 6 and 7.BioNTech | Results Presentation Deck | 43 slides · BioNTech
Conference presentation Investor relations Loop · Golden Circle1 hit
29
Clinical trial design diagram showing Part A (safety run-in) and Part B (randomization).BioNTech | Results Presentation Deck | 43 slides · BioNTech
Conference presentation Investor relations Loop · Golden Circle1 hit
30
The diagram uses a process flow structure to show patient progression from surgery through screening to treatment allocation.BioNTech | Results Presentation Deck | 43 slides · BioNTech
Conference presentation Investor relations Loop · Golden Circle1 hit
31
Includes a visual comparison of PK profiles (recombinant vs RiboCytokine) and a pipeline table for BNT151 and BNT152+153.BioNTech | Results Presentation Deck | 43 slides · BioNTech
Conference presentation Investor relations Loop · Golden Circle1 hit
32
Slide 32 of a presentation, likely BioNTech R&D day.BioNTech | Results Presentation Deck | 43 slides · BioNTech
Conference presentation Investor relations Loop · Golden Circle1 hit
33
The slide uses a three-column layout to categorize trial updates, phase 2 starts, and phase 1 starts.BioNTech | Results Presentation Deck | 43 slides · BioNTech
Conference presentation Investor relations Loop · Golden Circle1 hit
34
BioNTech | Results Presentation Deck | 43 slidesBioNTech | Results Presentation Deck | 43 slides · BioNTech
Conference presentation Investor relations Loop · Golden Circle1 hit
35
The table shows a significant increase in commercial revenues and operating profit compared to the prior year.BioNTech | Results Presentation Deck | 43 slides · BioNTech
Conference presentation Investor relations Beat · TeamLoop · Golden Circle1 hit
36
The chart uses a stacked bar format to decompose revenue into four categories, with a specific focus on COVID-19 vaccine revenue.BioNTech | Results Presentation Deck | 43 slides · BioNTech
Conference presentation Investor relations Beat · TeamLoop · Golden Circle1 hit
37
The slide uses a structured layout with three distinct sections for revenue, expenses, and tax.BioNTech | Results Presentation Deck | 43 slides · BioNTech
Conference presentation Investor relations Loop · Golden Circle1 hit
38
BioNTech | Results Presentation Deck | 43 slidesBioNTech | Results Presentation Deck | 43 slides · BioNTech
Conference presentation Investor relations Loop · Golden Circle1 hit
39
The slide uses a hub-and-spoke diagram to categorize therapeutic modalities. Bottom text highlights a specific recent transaction (Kite).BioNTech | Results Presentation Deck | 43 slides · BioNTech
Conference presentation Investor relations Loop · Golden Circle1 hit
40
BioNTech | Results Presentation Deck | 43 slidesBioNTech | Results Presentation Deck | 43 slides · BioNTech
Conference presentation Investor relations Loop · Golden Circle1 hit
41
Slide 41 from a BioNTech presentation.BioNTech | Results Presentation Deck | 43 slides · BioNTech
Conference presentation Investor relations Loop · Golden Circle1 hit
42
BioNTech | Results Presentation Deck | 43 slidesBioNTech | Results Presentation Deck | 43 slides · BioNTech
Conference presentation Investor relations Loop · Golden Circle1 hit
43
BioNTech | Results Presentation Deck | 43 slidesBioNTech | Results Presentation Deck | 43 slides · BioNTech
Conference presentation Investor relations 1 hit
01
Slide 1
Blue Apron | Results Presentation Deck | 17 slidesBlue Apron | Results Presentation Deck | 17 slides · Blue Apron
Conference presentation Investor relations Beat · Setup1 hit
02
Blue Apron | Results Presentation Deck | 17 slidesBlue Apron | Results Presentation Deck | 17 slides · Blue Apron
Conference presentation Investor relations Beat · Setup1 hit
03
Blue Apron | Results Presentation Deck | 17 slidesBlue Apron | Results Presentation Deck | 17 slides · Blue Apron
Conference presentation Investor relations Beat · Setup1 hit
04
Blue Apron | Results Presentation Deck | 17 slidesBlue Apron | Results Presentation Deck | 17 slides · Blue Apron
Conference presentation Investor relations 1 hit
05
Blue Apron | Results Presentation Deck | 17 slidesBlue Apron | Results Presentation Deck | 17 slides · Blue Apron
Conference presentation Investor relations Beat · EvidenceLoop · Cost Of Inaction1 hit
06
Blue Apron | Results Presentation Deck | 17 slidesBlue Apron | Results Presentation Deck | 17 slides · Blue Apron
Conference presentation Investor relations Beat · EvidenceLoop · Cost Of Inaction1 hit
07
Blue Apron | Results Presentation Deck | 17 slidesBlue Apron | Results Presentation Deck | 17 slides · Blue Apron
Conference presentation Investor relations Beat · EvidenceLoop · Cost Of Inaction1 hit
08
Blue Apron | Results Presentation Deck | 17 slidesBlue Apron | Results Presentation Deck | 17 slides · Blue Apron
Conference presentation Investor relations Beat · EvidenceLoop · Cost Of Inaction1 hit
09
The slide compares revenue and marketing spend trends over five quarters, highlighting the impact of pandemic-related demand fluctuations.Blue Apron | Results Presentation Deck | 17 slides · Blue Apron
Conference presentation Investor relations Beat · EvidenceLoop · Cost Of Inaction1 hit
10
Includes YoY growth percentages for each metric and detailed footnotes defining the metrics.Blue Apron | Results Presentation Deck | 17 slides · Blue Apron
Conference presentation Investor relations Beat · EvidenceLoop · Cost Of Inaction1 hit
11
PTG&A likely stands for Pre-opening, Technology, General & Administrative expenses.Blue Apron | Results Presentation Deck | 17 slides · Blue Apron
Conference presentation Investor relations Beat · EvidenceLoop · Cost Of Inaction1 hit
12
The slide compares financial performance across five quarters (Q2'20 to Q2'21).Blue Apron | Results Presentation Deck | 17 slides · Blue Apron
Conference presentation Investor relations Beat · EvidenceLoop · Cost Of Inaction1 hit
13
Decorative geometric border pattern.Blue Apron | Results Presentation Deck | 17 slides · Blue Apron
Conference presentation Investor relations Beat · Reflection1 hit
14
Blue Apron | Results Presentation Deck | 17 slidesBlue Apron | Results Presentation Deck | 17 slides · Blue Apron
Conference presentation Investor relations 1 hit
15
Blue Apron | Results Presentation Deck | 17 slidesBlue Apron | Results Presentation Deck | 17 slides · Blue Apron
Conference presentation Investor relations 1 hit
16
The table shows adjustments for share-based compensation, depreciation, and other non-operating items.Blue Apron | Results Presentation Deck | 17 slides · Blue Apron
Conference presentation Investor relations 1 hit
17
Blue Apron | Results Presentation Deck | 17 slidesBlue Apron | Results Presentation Deck | 17 slides · Blue Apron
Conference presentation Investor relations 1 hit
01
Slide 1
Broadridge Financial Solutions | Results Presentation Deck | 34 slidesBroadridge Financial Solutions | Results Presentation Deck | 34 slides · Broadridge
Conference presentation Investor relations Beat · Setup1 hit
02
Broadridge Financial Solutions | Results Presentation Deck | 34 slidesBroadridge Financial Solutions | Results Presentation Deck | 34 slides · Broadridge
Conference presentation Investor relations Beat · Setup1 hit
03
Broadridge Financial Solutions | Results Presentation Deck | 34 slidesBroadridge Financial Solutions | Results Presentation Deck | 34 slides · Broadridge
Conference presentation Investor relations Beat · Setup1 hit
04
Broadridge Financial Solutions | Results Presentation Deck | 34 slidesBroadridge Financial Solutions | Results Presentation Deck | 34 slides · Broadridge
Conference presentation Investor relations Beat · Setup1 hit
05
Broadridge Financial Solutions | Results Presentation Deck | 34 slidesBroadridge Financial Solutions | Results Presentation Deck | 34 slides · Broadridge
Conference presentation Investor relations Beat · Key Performance Indicators OverviewLoop · Logic Chain1 hit
06
Broadridge Financial Solutions | Results Presentation Deck | 34 slidesBroadridge Financial Solutions | Results Presentation Deck | 34 slides · Broadridge
Conference presentation Investor relations Beat · Key Performance Indicators OverviewLoop · Logic Chain1 hit
07
Broadridge Financial Solutions | Results Presentation Deck | 34 slidesBroadridge Financial Solutions | Results Presentation Deck | 34 slides · Broadridge
Conference presentation Investor relations Beat · Key Performance Indicators OverviewLoop · Logic Chain1 hit
08
Broadridge Financial Solutions | Results Presentation Deck | 34 slidesBroadridge Financial Solutions | Results Presentation Deck | 34 slides · Broadridge
Conference presentation Investor relations Beat · Key Performance Indicators OverviewLoop · Logic Chain1 hit
09
Includes Non-GAAP financial measures with a reference to disclosure slides.Broadridge Financial Solutions | Results Presentation Deck | 34 slides · Broadridge
Conference presentation Investor relations Beat · Key Performance Indicators OverviewLoop · Logic Chain1 hit